Page 7 - Recursion News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Recursion. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Recursion Today - Breaking & Trending Today

Recursion Publishes Second Annual Environmental, Social and Governance Report

Salt Lake City, March 28, 2023 Recursion , a clinical stage TechBio company leading the space by decoding biology to industrialize drug discovery, today announced the release of its second. | March 28, 2023 ....

Salt Lake City , United States , Chris Gibson , Morningstar Sustainalytics , Recursion Pharmaceuticals , United Nations Sustainable Development Goals Un Sdgs , Globenewswire Inc , Exchange Commission , Institutional Shareholder Services , Chief Executive Officer , Shareholder Services , Prime Rating , Accounting Standards Board , United Nations Sustainable Development Goals , Lake City , Francisco Bay , Securities Litigation Reform Act , Annual Report , Investor Contact , Nc Stock Exchange , Press Release , Ts Rxrx Us75629v1044 ,

Recursion to Participate in Upcoming Investor Conference

/PRNewswire/ Recursion (NASDAQ: RXRX), the clinical-stage biotechnology company industrializing drug discovery by decoding biology, today announced its. ....

Salt Lake City , United States , Global Biopharma Conference , San Francisco Bay ,

Recursion Releases MolRec, a Compound Intelligence Tool for Drug Discovery, Alongside the Largest of Its Kind Open-Source Dataset During First R&D Day

/PRNewswire/ Recursion (NASDAQ: RXRX), the clinical-stage biotechnology company industrializing drug discovery by decoding biology, announced the public. ....

Salt Lake City , United States , Chris Gibson , Ben Mabey , Compound Intelligence , Chief Technology Officer , Chief Executive Officer , Download Day , San Francisco Bay ,

Recursion to Participate in Upcoming Investor Conferences

/PRNewswire/ Recursion (NASDAQ: RXRX), the clinical-stage biotechnology company industrializing drug discovery by decoding biology, today announced its. ....

Salt Lake City , United States , Healthcare Conference , Annual Needham Growth Conference , San Francisco Bay ,

RECURSION PHARMACEUTICALS, INC. : Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)

Item 2.02. Results of Operations and Financial Condition.

On November 8, 2022, Recursion Pharmaceuticals, Inc. issued a press release
announcing its results of operations and financial condition for. | November 8, 2022 ....

Recursion Pharmaceuticals Inc , Exhibit Number Description , Securities Exchange , Securities Exchange Act , Securities Act , Exchange Act , Exhibit Number , Recursion Pharmaceuticals , Page Interactive Data File , Edgar Online , Nc Stock Exchange , Press Release , Ondition Rxrx Us75629v1044 ,